| a. Cytoplasm | ||
| b. Tissue | ||
| c. Neoplasm | ||
| d. Oncogene |
| a. Size | ||
| b. Growth pattern | ||
| c. Location of origin | ||
| d. Appearance |
| a. Invasive | ||
| b. Benign | ||
| c. Metastatic | ||
| d. Apoptotic |
| a. Studying yeast cell cultures | ||
| b. Conducting experiments using mice | ||
| c. Researching basic cell biology | ||
| d. All of the above |
| a. Describing the chemical structure of DNA | ||
| b. Outlining how cancer spreads | ||
| c. Identifying mutations that cause cancer | ||
| d. Establishing guidelines for cancer therapy |
| a. Carcinoma | ||
| b. Sarcoma | ||
| c. Lymphoma | ||
| d. Leukemia |
| a. Incurability | ||
| b. Loss of growth control | ||
| c. Origination in lymph | ||
| d. Contagiousness |
| a. He explained cancer development with autopsy findings. | ||
| b. He correlated cancer progression to microscopy findings. | ||
| c. He described the humoral theory. | ||
| d. He thought that cancer cells came from lymph. |
| a. When new cells are being formed faster than needed | ||
| b. When cell death surpasses cell division (growth) | ||
| c. When cell division equals cell death | ||
| d. When cells no longer divide |
| a. It was the first induced in lab animals. | ||
| b. It was the first known to be caused by a virus. | ||
| c. It developed because of the carcinogen tobacco. | ||
| d. It was caused by coal tar. |
| a. The theory that cancer is infectious is well established and proven true. | ||
| b. The theory that cancer is infectious led cancer patients years ago to be housed in the city near other people including doctors. | ||
| c. The theory that cancer is infectious was based on several members of the same household contracting breast cancer. | ||
| d. The theory that cancer is infectious explains how cancer cells spread within a person. |
| a. He described cancer as curable. | ||
| b. He did not believe in cancer. | ||
| c. He thought that cancer was incurable. | ||
| d. He outlined cancer treatments. |
| a. He developed anesthesia. | ||
| b. He performed autopsies. | ||
| c. He did radical mastectomies. | ||
| d. He explained that some tumors can be removed. |
| a. Celsus | ||
| b. Hunter | ||
| c. Hippocrates | ||
| d. House |
| a. Adenine | ||
| b. Guanine | ||
| c. Cytosine | ||
| d. Thymine |
| a. Thymine dimers | ||
| b. Frameshift mutations | ||
| c. Insertions | ||
| d. Chromosome breaks |
| a. Mismatch repair | ||
| b. Proofreading | ||
| c. Recombination | ||
| d. Apoptosis |
| a. Protein | ||
| b. Nucleic acid | ||
| c. Carbohydrate | ||
| d. Lipid |
| a. Nucleic acids | ||
| b. Amino acids | ||
| c. Monosaccharides | ||
| d. Lipids |
| a. Five | ||
| b. Three | ||
| c. Four | ||
| d. Two |
| a. One | ||
| b. Two | ||
| c. Three | ||
| d. Four |
| a. Create thymine dimers | ||
| b. Develop base substitutions | ||
| c. Have a frameshift mutation | ||
| d. Exchange adenine for guanine |
| a. Sucrose | ||
| b. Deoxyribose | ||
| c. Ribose | ||
| d. Fructose |
| a. To transfer phosphates | ||
| b. To remove phosphates | ||
| c. To bind to ligands | ||
| d. To block receptor binding |
| a. mRNA | ||
| b. tRNA | ||
| c. rRNA | ||
| d. sRNA |
| a. No further mutations occur. | ||
| b. There will be no impact on DNA. | ||
| c. DNA mutations will accumulate. | ||
| d. Only repair proteins will be impacted. |
| a. Cytoplasm | ||
| b. Mitochondria | ||
| c. Nucleus | ||
| d. Cell membrane |
| a. Tumor suppressors | ||
| b. Oncogenes | ||
| c. Proto-oncogenes | ||
| d. DNA repair genes |
| a. Ligand | ||
| b. GTP | ||
| c. Adenylyl cyclase | ||
| d. cAMP |
| a. Differentiation | ||
| b. The production of hormones | ||
| c. Proliferation of cells | ||
| d. Both A and C |
| a. Src | ||
| b. p53 | ||
| c. BRCA-1 | ||
| d. Rb |
| a. Ligands enter the cell and elicit their effect. | ||
| b. The receptor changes conformation and directly causes DNA transcription. | ||
| c. The signaling event is amplified inside the cell. | ||
| d. Signal transduction cascades run indefinitely. |
| a. Beta pleated sheet | ||
| b. Double helix | ||
| c. Single spiral | ||
| d. Hexagonal plane |
| a. By transferring a phosphate | ||
| b. By removing a methyl group | ||
| c. By binding to receptor on cell surface | ||
| d. By targeting DNA for transcription |
| a. G1 | ||
| b. S | ||
| c. G2 | ||
| d. M |
| a. Chromosomes line up in the center of the cell. | ||
| b. DNA is replicated. | ||
| c. The nuclear membrane disappears. | ||
| d. Proteins pull apart the chromosomes. |
| a. It is a type of eye cancer. | ||
| b. It is a transcription factor. | ||
| c. It is a tumor suppressor. | ||
| d. All of the above |
| a. Oncogenes | ||
| b. Tumor suppressors | ||
| c. DNA repair genes | ||
| d. Accessory proteins |
| a. Myc | ||
| b. p53 | ||
| c. Src | ||
| d. Rb |
| a. Myc | ||
| b. p53 | ||
| c. Src | ||
| d. Rb |
| a. G1/S | ||
| b. S/G2 | ||
| c. G2/M | ||
| d. Metaphase/anaphase transition |
| a. Cyclins | ||
| b. Cyclin dependent kinases | ||
| c. Tumor suppressors | ||
| d. Oncogenes |
| a. Inactivation of tumor suppressors | ||
| b. Mutations of DNA repair genes | ||
| c. Conversion of proto-oncogenes to oncogenes | ||
| d. All of the above |
| a. BRCA1 or BRCA2 testing is used to diagnose breast cancer. | ||
| b. BRCA1 or BRCA2 testing screens for an increased risk of developing breast cancer. | ||
| c. BRCA1 or BRCA2 testing is easily interpreted. | ||
| d. BRCA1 or BRCA2 testing is useful for patients that have breast cancer. |
| a. Myc | ||
| b. Src | ||
| c. p53 | ||
| d. Bcl-2 |
| a. G1 | ||
| b. S | ||
| c. G2 | ||
| d. M |
| a. Hyperplasia | ||
| b. Dysplasia | ||
| c. Anaplasia | ||
| d. Carcinoma in situ |
| a. Breast | ||
| b. Cervix | ||
| c. Liver | ||
| d. Lung |
| a. Dysplasia | ||
| b. Carcinoma in situ | ||
| c. Hyperplasia | ||
| d. Anaplasia |
| a. To develop a polio vaccine | ||
| b. To study genetics | ||
| c. To conduct numerous scientific studies | ||
| d. All of the above |
| a. Stimulate death receptor clustering | ||
| b. Directly target caspase | ||
| c. Block lipid raft fusion | ||
| d. Turn off the process of apoptosis |
| a. 4 months | ||
| b. 3 days | ||
| c. 2 weeks | ||
| d. 1 hour |
| a. It progresses. | ||
| b. It is arrested. | ||
| c. It takes twice as long. | ||
| d. It requires p53. |
| a. Ionizing radiation | ||
| b. Depletion of growth factors and nutrients needed to survive | ||
| c. Infection of the cell by a virus | ||
| d. All of the above |
| a. Binding of B lymphocytes to death receptors | ||
| b. Signals from the mitochondria | ||
| c. Granzyme | ||
| d. Caspase |
| a. p53 | ||
| b. Myc | ||
| c. IGF | ||
| d. Bcl-2 |
| a. Caspase | ||
| b. p53 | ||
| c. Telomerase | ||
| d. Ras |
| a. It comes before initiation. | ||
| b. It does not require initiation. | ||
| c. More promoters will lead to a more pronounced risk. | ||
| d. Low levels of promoters will not likely cause tumor promotion. |
| a. Sarcomas | ||
| b. Carcinomas | ||
| c. Blastomas | ||
| d. All of the above |
| a. Telomeres are replaced. | ||
| b. Telomeres are removed. | ||
| c. Telomeres lengthen. | ||
| d. Telomeres shorten. |
| a. Necrosis | ||
| b. Apoptosis | ||
| c. Replication | ||
| d. Mutation |
| a. Stimulate growth factors. | ||
| b. Induce angiogenesis. | ||
| c. Build the basement membrane. | ||
| d. Destroy extracellular matrix (ECM). |
| a. Oncogenesis | ||
| b. Metastasis | ||
| c. Angiogenesis | ||
| d. Anaplasia |
| a. Adrenal | ||
| b. Lung | ||
| c. Liver | ||
| d. Renal |
| a. Heart | ||
| b. Lungs | ||
| c. Liver | ||
| d. Cervix |
| a. Adhesion molecules | ||
| b. The absence of growth factors | ||
| c. The blood vessel size supplying that tissue | ||
| d. Platelets |
| a. Breast | ||
| b. Lung | ||
| c. Blood | ||
| d. Colon |
| a. VEGF | ||
| b. bFGF | ||
| c. Endostatin | ||
| d. p53 |
| a. In the blood | ||
| b. In the lymphatic system | ||
| c. Through body walls | ||
| d. Via the gastrointestinal tract |
| a. VEGF | ||
| b. p53 | ||
| c. Ras | ||
| d. BRCA1 |
| a. Everyone has slightly different lymphatic networks. | ||
| b. More cells are found in lymph than in blood, making it hard to spot cancer cells. | ||
| c. Tumor cells do not interact with the lymphatic vessels. | ||
| d. Lymph nodes hide cancer cells, making it difficult to detect them there. |
| a. Angiogenesis | ||
| b. Oncoprogression | ||
| c. Hitching | ||
| d. Metastasis |
| a. An initiator | ||
| b. An inducer | ||
| c. A promoter | ||
| d. Both A and C |
| a. Proliferation | ||
| b. Biotransformation | ||
| c. Promotion | ||
| d. Induction |
| a. In an animal model | ||
| b. In a single concentration | ||
| c. In isolation | ||
| d. At high rates of speed |
| a. Cervical | ||
| b. Endometrial | ||
| c. Breast | ||
| d. Bladder |
| a. Genetics | ||
| b. Environmental factors | ||
| c. Nutritional status | ||
| d. Older age |
| a. 1 | ||
| b. 2A | ||
| c. 2B | ||
| d. 3 |
| a. Time of exposure | ||
| b. Potency | ||
| c. Dose-response | ||
| d. All of the above |
| a. Literacy | ||
| b. Race | ||
| c. Gender | ||
| d. Income |
| a. UV radiation | ||
| b. Oxygen free radicals | ||
| c. Genetics | ||
| d. Viruses |
| a. Smoking | ||
| b. Asbestos | ||
| c. Radon | ||
| d. Arsenic |
| a. Aflatoxins | ||
| b. Benzene | ||
| c. Hepatitis B and C viruses | ||
| d. Alcohol |
| a. Breast | ||
| b. Lung | ||
| c. Colorectal | ||
| d. Prostate |
| a. Breast cancer | ||
| b. Colon cancer | ||
| c. Cervical cancer | ||
| d. Lung cancer |
| a. 35 | ||
| b. 45 | ||
| c. 40 | ||
| d. 50 |
| a. No later than 21 | ||
| b. 30 | ||
| c. Before 21 if sexually active | ||
| d. Both A and C |
| a. Microarray | ||
| b. Mammogram | ||
| c. Biopsy | ||
| d. Oncogram |
| a. Metastasis | ||
| b. Loss of cell growth | ||
| c. Patient's chance of survival | ||
| d. Risk for secondary infection |
| a. UV radiation | ||
| b. Tobacco smoking | ||
| c. Radioisotopes | ||
| d. Genetics |
| a. Sarcoma | ||
| b. Blastoma | ||
| c. Carcinoma | ||
| d. Melanoma |
| a. Breast cancer | ||
| b. Cervical cancer | ||
| c. Prostate cancer | ||
| d. Colon cancer |
| a. Eat a high fiber diet | ||
| b. Exercise daily | ||
| c. Avoid tobacco | ||
| d. Have an annual check-up |
| a. Environmental exposure | ||
| b. Genetic predisposition | ||
| c. Dietary intake | ||
| d. Medical status |
| a. Tobacco | ||
| b. Poor diet | ||
| c. Alcohol | ||
| d. Both A and C |
| a. Pap | ||
| b. Mammogram | ||
| c. PSA | ||
| d. Fecal occult blood |
| a. Pap | ||
| b. Mammogram | ||
| c. PSA | ||
| d. Fecal occult blood |
| a. Screening methods provide a definitive diagnosis. | ||
| b. Screening methods are used to detect cancer in patients without symptoms. | ||
| c. Screening methods should only be used if a patient has cancer symptoms. | ||
| d. Screening methods have not made a significant impact on cancer prognosis. |
| a. They mark cancer cells to be killed. | ||
| b. They block important receptors on cancer cells. | ||
| c. They carry toxic substances to the cancer cells. | ||
| d. Both A and C |
| a. Radiation | ||
| b. Immunotherapy | ||
| c. Chemotherapy | ||
| d. Both A and C |
| a. Methotrexate | ||
| b. Doxil | ||
| c. Mustard gas | ||
| d. Avastin |
| a. Chronic myelogenous leukemia | ||
| b. Lymphoma | ||
| c. Kaposi's Sarcoma | ||
| d. Acute colon cancer |
| a. Cells lining the gastrointestinal track | ||
| b. Cancer cells | ||
| c. Bone marrow cells | ||
| d. Skeletal muscle cells |
| a. Inducing apoptosis | ||
| b. Cell division | ||
| c. Cancer cell proliferation | ||
| d. Signaling |
| a. Spindle promoter | ||
| b. Antimetabolite | ||
| c. Genotoxic agent | ||
| d. Purine and pyrimidine antagonists |
| a. Kinase inhibitor | ||
| b. Angiogenesis inhibitor | ||
| c. Antimetabolites | ||
| d. Antisense oligonucleotides |
| a. It is toxic to normal cells. | ||
| b. The same siRNA cannot be used a second time if cancer returns. | ||
| c. It is impossible to get siRNA into cells. | ||
| d. siRNA stimulates an immune response. |
| a. Lentivirus | ||
| b. Adenovirus | ||
| c. Herpes simplex virus | ||
| d. Epstein Barr Virus |
| a. To repair damaged tissues | ||
| b. For long term maintenance | ||
| c. To divide into tissue that will form organs | ||
| d. To complete body tissues |
| a. Esophagus | ||
| b. Lung | ||
| c. Prostate | ||
| d. Colon |